Tagged with R&D

R&D Pfizer Turkey has taken a strong supporting role in Turkey’s current strategic development plan by localizing the production of their Prix Galien winning Prevnar vaccine. Country Manager Elif Aral discusses this facility’s role as a role model in the industry, and how the country can improve investment incentives to better…

UCB UCB’s managing director for Turkey and the MEA region discusses UCB’s leading patient centricity, how UCB is addressing gaps in the Turkish healthcare system surrounding epileptic patients, and the company’s plan for regional expansion through partnerships. Given your patient centricity and UCB’s unique perspective, how would you assess the sectors approach…

innovation Innovation is a product’s added value, ensuring that the patient is ready to buy. The former director of R&D and today CEO of Carnot explains how the company is undergoing a process of professionalization with incremental innovation and exports as two of the company’s most important priorities. You have been…

MSD Guillermo Browne, Managing Director of MSD Peru, talks about the turnover of the affiliate and the company’s success in bringing new innovation to the country, particularly in the areas of vaccines and oncology. You arrived in Peru in January 2014. What initial tasks did you set for yourself? When I arrived, MSD…

manufacturing The director general of Cooper Pharma explains how the company has become the leading Moroccan player, why Morocco´s relationship with Africa is one of cooperation not exploitation, and how the country now needs to look towards innovation if it is to compete.   Cooper Pharma celebrated its 80th anniversary in…

government ‘Poverty is fought with health, education and, above all, employment and more employment’. This is the vision Carlos Slim has for Mexico. The CEO of the Carlos Slim Foundation discusses how the foundation is actively involved in shaking up the system to bring innovation – and energy – to health.…

R&D “When I left Janssen, I never imagined joining a Korean company,” recalls Choi Tae-Hung, sipping a freshly brewed yujacha tea in his office on a crisp autumn morning as he gazes down at the busy, sundrenched streets of Seoul below. “I thought that the global business of Korean pharmaceutical companies…

Sanofi The president and director general of Sanofi Morocco talks about the impact of public/private partnerships for the development of the Moroccan health sector, explains why 2013 was the African year for Sanofi and stresses the importance of visibility if Sanofi is to continue investing in large regional projects in the…

GSK Morocco has become GSK’s regional hub thanks to the quality of human capital in the country, explains the company’s area director, president and general manager for North Africa, who also comments on the reason why she remains optimistic for the future of Moroccan pharmaceutical industry.   We have heard from the industry…

Novartis The country president and general director of Novartis Morocco discusses the impact of the price cuts on the pharma market, the need to change the health culture in the country and the importance of Morocco as a hub.   As well as being the country president of Novartis Morocco, you…

R&D The CEO of Mega Medical, a Korean medical equipment manufacturer specialized in the ENT area, discusses his firm’s recent expansion into the anti-obesity segment, their strategy for building a global business, and the overall potential of the Korean medical equipment sector.     Korea still relies primarily on imported medical…

R&D Andres Matesanz, general manager of ChemSwiss Mexico, shares his views on the Mexican API industry and its regulations as well as his personal ambitions for the company’s future.    You started the operations of ChemSwiss here in Mexico in January 2012. What mission did the headquarters entrust you with? The…